QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: How EU Pharmaceutical Legislation Is Structured

Test your understanding of the concepts covered by How EU Pharmaceutical Legislation Is Structured.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A regulatory professional is assessing a nationally authorised medicine and needs to determine the applicable national administrative powers. Which source combination is most appropriate?

Only Regulation (EC) No 726/2004, because all medicines regulation is centralised at EU level. Only an EMA guideline, because administrative powers are described in procedural guidance. Directive 2001/83/EC together with the relevant national implementing legislation and administrative rules. Only the product's assessment report, because it records the complete legal framework.

Question 2 of 10 A legal provision refers to a defined term, another article and an annex. What is the most reliable interpretive approach?

Read only the sentence containing the obligation. Use the ordinary-language meaning of the defined term and ignore the annex. Follow the cross-references, check the applicable definitions and read the annex as part of the relevant instrument. Assume that cross-references are merely editorial and optional.

Question 3 of 10 What is the most accurate description of the relationship between Regulation (EC) No 726/2004 and Directive 2001/83/EC?

They are interchangeable names for the same legal instrument. The regulation applies only to scientific guidance, while the directive applies only to national fees. They structure different but interconnected parts of the EU medicines framework, and the relevant product route and procedure determine which provisions apply. The directive automatically repeals the regulation for all post-authorisation matters.

Question 4 of 10 Why should a citation such as 'Article 31' normally be regarded as incomplete?

Article numbers are never legally relevant in EU medicines regulation. The citation does not identify the instrument, version and potentially applicable amendments containing that article. Article numbers may be used only in national legislation, not in EU legislation. An article citation is valid only if accompanied by an EMA press release.

Question 5 of 10 A professional searches EudraLex for the legal basis of a pharmacovigilance obligation. What is the most appropriate use of the collection?

Treat every EudraLex document as having the same legal force. Start with relevant legislation, such as material in Volume 1, and distinguish it from guidance and notices in other volumes. Use only Volume 2 because all pharmacovigilance requirements are guidance-based. Assume that inclusion in EudraLex converts a guideline into legislation.

Question 6 of 10 Why can a current consolidated text be insufficient for reconstructing the legal basis of a historical regulatory decision?

Consolidated texts are never useful for legal interpretation. Historical decisions are governed only by guidance, not legislation. The wording applicable at the historical date may differ from the current amended wording, and transitional provisions may also matter. A consolidated text cannot contain provisions from directives.

Question 7 of 10 A regulatory team finds an apparent inconsistency between a current EMA guideline and an applicable EU regulation. What is the best response?

Automatically follow the guideline because it is more recent. Automatically ignore the guideline without documenting the issue. First determine whether the documents address different levels or aspects of the issue; if a genuine conflict remains, give precedence to the legally authoritative instrument and document the discrepancy. Treat the regulation and guideline as equal sources and choose the more convenient interpretation.

Question 8 of 10 Which information set most effectively supports an auditable regulatory conclusion?

Document title and a general description of the agency's position Instrument, issuing authority, legal basis and effect, together with the relevant provision and version or date A link to a secondary article without identifying the primary source The name of the product and the date of the internal discussion only

Question 9 of 10 A company argues that an EU guideline can be disregarded because it is not legislation. What is the most appropriate regulatory response?

The guideline is always legally binding because it was issued by an EU institution. The guideline has no practical relevance unless it has been transposed into national law. The guideline should be considered as operationally important, while the underlying legal obligation and consequences of divergence are assessed separately. The guideline automatically overrides any inconsistent provision in a regulation.

Question 10 of 10 An amendment is published on 1 June, enters into force on 21 June and applies from 1 January of the following year, subject to transitional provisions. Which date is most relevant when deciding whether a new obligation applies to a submission made in July?

The publication date only The entry-into-force date only The date of application together with any relevant transitional provisions The date on which the agency first publishes a summary

Knowledge Assessment: How EU Pharmaceutical Legislation Is Structured

Cookie Settings